Combined therapy with zidovudine, recombinant granulocyte colony stimulating factors and erythropoietin in asymptomatic HIV patients

Journal of Chemotherapy

Volumn 8, Issue 1, 1996, Pages 63-66

  Perrella, O ^a,b   Finelli, E ^a   Perrella, A ^a   Tartaglia, G ^a   Scognamiglio, P ^a   Scalera, G ^a  

^a AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^b NONE   (Italy)

Author keywords

Erythropoietin; Human immunodeficiency virus; Recombinant granulocyte colony stimulating factors; Zidovudine

Indexed keywords

AMINOTRANSFERASE; BETA 2 MICROGLOBULIN; CD4 ANTIGEN; ERYTHROPOIETIN; FERRITIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; ZIDOVUDINE;

ADULT; ARTICLE; BLOOD TOXICITY; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NEUTROPHIL COUNT; RANDOMIZED CONTROLLED TRIAL;

EID: 0030025437     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1996.8.1.63     Document Type: Article

References (12)

1. Volberding PA, Lagakos SW, Koch MA. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4 positive cells per cubic millimeter. N Engl J Med 1990; 322:941-7.
2. Richman DD, Fischl MA, Grieco MH. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987; 317: 192-9.
3. Fischl MA, Richman DD, Causey DM. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. JAMA 1989; 267: 2405-9.
4. Groopman J. Status of colony-stimulating factors in cancer and AIDS. Semin Oncol 1990; 17 (suppl. 1): 31-8.
5. Miles SA, Mitsuyasu RT, Moreno J et al. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zodivudine. Blood 1991; 77: 2109-14.
6. Fischl MA, Galpin JE, Levin JD et al. Human recombinant erythropoietin therapy for AIDS patients treated with AZT: a double-blind, placebo-controlled clinical study. N Engl J Med 1990; 322: 1488-94.
7. Centers for Disease Control. Revision of the case definition of acquired immunodeficiency syndrome for national reporting. US MMWR 1985; 34: 373-75.
8. Perrella O, Perrella A, Soscia E et al. What is the role of T-lymphocytes with gamma/delta receptors in Pneumocystis carinii pneumonia in AIDS patients? AIDS 1994; 8: 395.
9. Fischl MA, Richman DD, Grieco MH et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987; 317: 185-9.
10. Fischl MA, Parker CB, Pettinelli C et al. A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. N Engl J Med 1990; 323: 1009-14.
11. Jackson GG, Paul DA, Falk LA et al. Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT). Ann Intern Med 1988; 108: 175-8.
12. Collier AC, Bozzette S, Coombs RW et al. A pilot study of low-dose zidovudine in human immunodeficiency virus infection. N Engl J Med 1990; 323: 1015-20.